Marinus Pharmaceuticals Inc (MEX:MRNS)
MXN 5.25 0 (0%) Market Cap: 414.73 Mil Enterprise Value: 694.13 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 26/100

Marinus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 03:20PM GMT
Release Date Price: MXN314.7
Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Hi, everyone, and welcome to the Cowen Health Care Conference. It is my pleasure to have with us today Marinus Pharmaceuticals and specifically, CEO, Dr. Scott Braunstein; and COO, Dr. Joe Hulihan. Thank you both for joining us for an interesting discussion today.

Questions & Answers

Joseph John;Charles Thome
Cowen and Company, LLC, Research Division - VP of Healthcare

Scott, maybe just to kick things off. You had a great 2020. Maybe if you wanted to highlight some of the most recent accomplishments and kind of what do you see as the key milestones for 2021?

Scott N. Braunstein
Marinus Pharmaceuticals, Inc. - CEO, President & Director

Thanks for having us, Joe. And we're looking forward to the year ahead. The first 6 to 9 months of this year for us is really a little bit more focused on the oral in terms of data sets.

We had our Phase III Marigold Study readout in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot